While the leading vaccine manufacturers – by value at least – are western big pharma companies, Indian manufacturers actually produce around 60% of all global vaccines by volume, and so are set to play an essential role to meet global demand for a potential coronavirus vaccine.
Coronavirus TV: Vaccine Expertise And R&D In India
Vibha Ravi, the Mumbai-based subeditor within Scrip's APAC content team, talks about how Indian firms are stepping up to the challenge of developing a coronavirus vaccine in this episode of Pharma Intelligence's Coronavirus TV.
